
Roche revises CellCept's prescribing information
Changes have been made to the Warnings and Adverse Reactions sections to the immunosuppressant.
Roche Laboratories has announced that it has made changes to the Warnings and Adverse Reactions sections to the immunosuppressant
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


























































































































































